Alligator Bioscience AB GAAP EPS of -SEK 0.34, revenue of SEK 0.47M

Published 2 weeks ago Positive
Alligator Bioscience AB GAAP EPS of -SEK 0.34, revenue of SEK 0.47M
Auto
* Alligator Bioscience AB (publ) press release [https://alligatorbioscience.se/en/mfn_news/alligator-bioscience-ab-reports-financial-results-for-q3-2025-and-provides-a-business-update/] (OTC:ALLGF [https://seekingalpha.com/symbol/ALLGF]): Q3 GAAP EPS of -SEK 0.34.
* Revenue of SEK 0.47M (-66.4% Y/Y).
* Upcoming rights issue of approx. SEK 120 million (gross), providing 6–9 months of financial runway during 2026, announced 22 October.

MORE ON ALLIGATOR BIOSCIENCE AB (PUBL)

* Financial information for Alligator Bioscience AB (publ) [https://seekingalpha.com/symbol/ALLGF/income-statement]